Xie D - Search Results

1

Imprinting status of DLK1 gene in brain tumors and lymphomas.

Yin D, Xie D, De Vos S, Liu G, Miller CW, Black KL, Koeffler HP. Yin D, et al. Among authors: xie d. Int J Oncol. 2004 Apr;24(4):1011-5. Int J Oncol. 2004. PMID: 15010842

2

Discovery of over-expressed genes and genetic alterations in breast cancer cells using a combination of suppression subtractive hybridization, multiplex FISH and comparative genomic hybridization.

Xie D, Jauch A, Miller CW, Bartram CR, Koeffler HP. Xie D, et al. Int J Oncol. 2002 Sep;21(3):499-507. Int J Oncol. 2002. PMID: 12168092

3

TMEFF1 and brain tumors.

Gery S, Yin D, Xie D, Black KL, Koeffler HP. Gery S, et al. Among authors: xie d. Oncogene. 2003 May 8;22(18):2723-7. doi: 10.1038/sj.onc.1206351. Oncogene. 2003. PMID: 12743596

4

DLK1: increased expression in gliomas and associated with oncogenic activities.

Yin D, Xie D, Sakajiri S, Miller CW, Zhu H, Popoviciu ML, Said JW, Black KL, Koeffler HP. Yin D, et al. Among authors: xie d. Oncogene. 2006 Mar 23;25(13):1852-61. doi: 10.1038/sj.onc.1209219. Oncogene. 2006. PMID: 16288219

5

Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors.

Yin D, Xie D, Hofmann WK, Miller CW, Black KL, Koeffler HP. Yin D, et al. Among authors: xie d. Oncogene. 2002 Nov 28;21(54):8372-8. doi: 10.1038/sj.onc.1206031. Oncogene. 2002. PMID: 12447702

6

DNA repair gene O6-methylguanine-DNA methyltransferase: promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumors.

Yin D, Xie D, Hofmann WK, Zhang W, Asotra K, Wong R, Black KL, Koeffler HP. Yin D, et al. Among authors: xie d. Mol Carcinog. 2003 Jan;36(1):23-31. doi: 10.1002/mc.10094. Mol Carcinog. 2003. PMID: 12503076

7

NADE (p75NTR-associated cell death executor) suppresses cellular growth in vivo.

Tong X, Xie D, Roth W, Reed J, Koeffler HP. Tong X, et al. Among authors: xie d. Int J Oncol. 2003 Jun;22(6):1357-62. Int J Oncol. 2003. PMID: 12739005

8

Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas.

Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, Koeffler HP. Xie D, et al. Clin Cancer Res. 2004 Mar 15;10(6):2072-81. doi: 10.1158/1078-0432.ccr-0659-03. Clin Cancer Res. 2004. PMID: 15041728

9

AIM-2: a novel tumor antigen is expressed and presented by human glioma cells.

Liu G, Yu JS, Zeng G, Yin D, Xie D, Black KL, Ying H. Liu G, et al. Among authors: xie d. J Immunother. 2004 May-Jun;27(3):220-6. doi: 10.1097/00002371-200405000-00006. J Immunother. 2004. PMID: 15076139

10

Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.

Gery S, Xie D, Yin D, Gabra H, Miller C, Wang H, Scott D, Yi WS, Popoviciu ML, Said JW, Koeffler HP. Gery S, et al. Among authors: xie d. Clin Cancer Res. 2005 Oct 15;11(20):7243-54. doi: 10.1158/1078-0432.CCR-05-0231. Clin Cancer Res. 2005. PMID: 16243794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,505 results

Search Page

Filters